David T Ho

Title: The Innovative Contributions of David T. Ho

Introduction

David T. Ho is a prominent inventor based in Long Beach, CA, known for his significant contributions to the field of biomedical engineering. With a total of 8 patents to his name, he has made remarkable strides in developing novel antigen binding constructs and therapeutic methods.

Latest Patents

Among his latest patents, Ho has developed antigen binding constructs that specifically target CD8. These constructs include antibodies and antibody fragments, such as scFv, minibodies, and cys-diabodies, which are designed to bind to CD8. Additionally, he has created methods for utilizing these constructs in various applications. Another notable patent involves J591 minibodies and cys-diabodies aimed at targeting human prostate-specific membrane antigen (PSMA). This patent describes a minibody monomer that binds PSMA, encoded by a nucleotide sequence that includes an scFv sequence, an artificial hinge sequence, and a human IgG CH3 sequence. Furthermore, methods for diagnosing or treating cancers associated with PSMA expression are also provided in his work.

Career Highlights

Throughout his career, David T. Ho has worked with several innovative companies, including Imaginab, Inc. and Nantbio, Inc. His work has significantly impacted the development of targeted therapies in oncology and immunology.

Collaborations

Ho has collaborated with notable professionals in his field, including Tove Olafsen and Christian P. Behrenbruch. These collaborations have further enhanced his research and development efforts.

Conclusion

David T. Ho's contributions to the field of biomedical engineering through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer treatment and immunotherapy.